Backed by R&D Strength, Jiudian Goes Public on A-share Market｜JD Star
CNStock reported that on October 10, Jiudian Pharmaceutical Co., Ltd., a large pharmaceutical corporation in Hunan, went public on GEM of Shenzhen Stock Exchange. The IPO will include no more than 29,340,000 shares, accounting for 25% of post-IPO total capital of the company. The price is RMB 10.37 per share. The fund ran by JD Capital became a shareholder of Jiudian in 2013 and holds 10% of its shares prior to IPO.
- Jiuding Group
- JT Asset Management
- JX AMC